Question 1

What insurance policy changes affect HCPCS J2997?

Accepted Answer

There are 1 tracked policy change affecting HCPCS J2997, including updates from Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Question 2

Which payers have updated policy for HCPCS J2997?

Accepted Answer

Payers that have issued tracked updates for HCPCS J2997 include: Independence Blue Cross.

Question 3

How do I get notified when HCPCS J2997 policy changes?

Accepted Answer

Create a free account at PolicyChanges.app and save a search filtered to HCPCS J2997. You will receive a daily digest email whenever a new policy change references this code.

Question 4

Why do payers change policies for HCPCS J2997?

Accepted Answer

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

J2997 Insurance Policy Changes

08.01.26e, Enzyme Replacement Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (e.g., elapegademase-lvlr [Revcovi])